XML 13 R2.htm IDEA: XBRL DOCUMENT v3.21.2
Unaudited Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2021
Dec. 31, 2020
Current assets:    
Cash and cash equivalents $ 572,609 $ 21,496
Restricted cash 39,900 19,700
Accounts receivable (net of allowance for doubtful accounts of $5,047 and $4,796 as of December 31, 2020 and September 30, 2021, respectively) 67,243 76,298
Notes receivable 10,260 20,839
Inventories, net 47,820 44,968
Prepaid expenses and other current assets 12,964 6,022
Amount due from related parties 128
Total Current Assets 750,924 189,323
Property, plant and equipment, net 222,771 198,017
Land use rights, net 13,935 14,001
Acquired intangible assets, net 2,024 2,279
Other non-current assets 702 890
Total Assets 990,356 404,510
Current liabilities:    
Accounts payable 36,557 42,007
Advance from customers 2,343 2,446
Accrued expenses and other current liabilities 48,065 60,628
Income tax payables 665 664
Short-term bank borrowings 22,851 12,184
Notes payable 43,131 35,782
Bonds payable 29,915
Total Current Liabilities 153,612 183,626
Deposit liability for series B2 convertible preferred shares (“Series B2 Preferred”) 21,792
Long-term bonds payable 73,147 73,147
Warrant liability 2,461
Share-based compensation liability 8,841
Other non-current liabilities 35,511 110,597
Total Liabilities 273,572 389,162
Mezzanine Equity (Note 14 and Note 16)    
Series C1 convertible redeemable preferred shares (“Series C1 Preferred”) (US$0.01 par value; 26,757,258 authorized, issued and outstanding as of December 31, 2020 and nil authorized, issued and outstanding as of September 30, 2021) 80,581
Series C2 convertible redeemable preferred shares (“Series C2 Preferred”) (US$0.01 par value; 20,249,450 authorized, issued and outstanding as of December 31, 2020 and nil authorized, issued and outstanding as of September 30, 2021) 81,966
Series D1 convertible redeemable preferred shares (“Series D1 Preferred”) (US$0.01 par value; 22,311,516 authorized, issued and outstanding as of December 31, 2020 and nil authorized, issued and outstanding as of September 30, 2021) 146,583
Redeemable noncontrolling interests 90,820
Total Mezzanine Equity 399,950
Commitments and contingencies (Note 21)
Shareholders’ Equity    
Common Stock (par value of US$0.0001 per share, 240,450,000 and 750,000,000 shares authorized as of December 31, 2020 and September 30, 2021; 99,028,297 and 300,522,394 shares issued, and 99,028,297 and 298,834,894 shares outstanding as of December 31, 2020 and September 30, 2021) 30 6
Additional paid-in capital 1,291,199
Statutory reserves 6,032 6,032
Accumulated deficit (585,460) (397,996)
Accumulated other comprehensive income 4,983 7,356
Total Shareholders’ (Deficit)/Equity 716,784 (384,602)
Total Liabilities, Mezzanine Equity and Shareholders’ Equity $ 990,356 $ 404,510